Fellow & Resident

Fellow & Resident

Fellow & Resident

HD Visual Learning

Best Practices in Anti-VEGF Injection Therapy Techniques

Visualize important aspects of intravitreal injection preparation and technique, as well as recognition of contraindications to injection and essential elements of post-injection assessment.

The Growing Importance of Gene Therapy in the Management of Retinal Diseases

Understanding the mechanisms of gene therapy, how it is delivered and the potential impact on treatment of retinal diseases as well as investigating benefits and burdens as compared to approved therapies and dosing strategies.

The Impact of Clinical Trials in the Management of Polypoidal Choroidal Neovascularization (PCV)

Examination of essential diagnostic tools, distinguishing features of PCV, and how clinical trials for anti-vascular endothelial growth factor (anti-VEGF) agents with both monotherapy and combination photodynamic therapy have impacted management of this macula-scarring disease.

The Impact of Clinical Trials in the Management of Myopic Choroidal Neovascularization (mCNV)

Investigation of critical features of mCNV and how clinical trials for anti-vascular endothelial growth factor (anti-VEGF) agents have impacted the management of this vision-threatening complication of pathologic myopia.

The Impact of Clinical Trials in the Management of Retinal Vein Occlusion

Exploration of how clinical trials and advancements in treatment with intravitreal vascular endothelial growth factor (VEGF) inhibitors have impacted the management of Retinal Vein Occlusion.

The Impact of Clinical Trials in the Management of Age-Related Macular Degeneration

Exploration of how clinical trials and advancements in treatment with intravitreal vascular endothelial growth factor (VEGF) inhibitors have impacted the management of Age-Related Macular Degeneration.

The Impact of Clinical Trials in the Management of DR and DME

Exploration of how clinical trials and advancements in treatment with intravitreal vascular endothelial growth factor (VEGF) inhibitors have impacted the management of diabetic retinopathy (DR) and diabetic macular edema (DME).

This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019Med Learning Group. Built by Divigner. All Rights Reserved.

Pin It on Pinterest

Directory
Scroll to Top

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers